LRF Showcases Impressive Number of Researchers at 2020 American Society of Hematology Annual Meeting
LRF Scientific Advisory Board Members joined by current and former grantees at the 62nd ASH Annual Meeting & Exposition
LRF Scientific Advisory Board Members joined by current and former grantees at the 62nd ASH Annual Meeting & Exposition

In May 2020, lymphoma-expert, Raghuveer Ranganthan, MD (Univerity of Southern California) hosted the Lymphoma Research Foundation’s Update on CAR T-Cell Therapy in Diffuse Large B-cell Lymphoma Webinar. Due to the interest surrounding CAR T-cell therapy to treat various types of…

During the Lymphoma Research Foundation’s Denver Ask the Doctor About Lymphoma Program, lymphoma-expert and program host, John M. Burke, MD (Rocky Mountain Cancer Center), provided the following answer to this question: How can patients access innovative drug treatments when insurance…

A father and daughter’s story as both lymphoma survivors and each other’s caregivers, and their mission to empower themselves through education and connect with others at Lymphoma Research Foundation (LRF)’s North American Educational Forum on Lymphoma.

The Lymphoma Research Foundation (LRF) welcomed three new members to its elite Scientific Advisory Board (SAB) on July 1. The new members represent distinct specialties that will contribute to the global impact of the Foundation.

Dr. Manali Kamdar’s unique and empathetic approach to patient care and lymphoma research leaves a lasting impact on the lymphoma community.

Former Pharmaceutical Executive Joins Lymphoma Research Foundation Board of Directors

Established through the generosity of the Peykoff Family and Niagara Cares, the $10 million Initiative is poised to transform the follicular lymphoma treatment landscape for tens of thousands of patients by harnessing LRF’s unique resources, convening the world’s experts in follicular lymphoma research and patient care, and driving direct investment in clinical research.
The tenth anniversary of the Lymphoma Research Foundation’s Blood Cancer Awareness Month initiative expected to reach millions.

Foundation to Celebrate Achievements of Honorees AstraZeneca, Thomas M. Habermann, MD and Heroes Among the Lymphoma Community